Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha

Establishment of a yeast-based VLP platform for antigen presentation

(2018) David Wetzel et al.   Microbial Cell Factories

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

(2018) Wei-Chiao Huang et al.   Nature Nanotechnology

Production of virus-like particles for vaccines

(2017) J. Fuenmayor et al.   New Biotechnology

Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines

(2017) Darren B. Leneghan et al.   Scientific Reports

Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of thePlasmodium falciparumSexual Stage Protein Pfs230

(2016) Nicholas J. MacDonald et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Naturally acquired immunity to sexual stage P. falciparum parasites

(2016) WILL J. R. STONE et al.   PARASITOLOGY

Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

(2016) Sharan Bobbala et al.   PHARMACEUTICAL RESEARCH

Engineering virus-like particles as vaccine platforms

(2016) Kathryn M Frietze et al.   Current Opinion in Virology

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology

(2016) Yuanyuan Li et al.   Scientific Reports

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization

(2016) Karl D. Brune et al.   Scientific Reports

Toward the development of effective transmission-blocking vaccines for malaria

(2015) Daria Nikolaeva et al.   Expert Review of Vaccines

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

(2015)   LANCET

Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles

(2015) Rajesh Kumar et al.   VACCINE

Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production

(2014) Mudassar Ahmad et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Subviral particle as vaccine and vaccine platform

(2014) Ming Tan et al.   Current Opinion in Virology

Functional Comparison of Plasmodium falciparum Transmission-Blocking Vaccine Candidates by the Standard Membrane-Feeding Assay

(2013) Kazutoyo Miura et al.   INFECTION AND IMMUNITY

A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice

(2013) R. Mark Jones et al.   PLoS One

Use of baculovirus expression system for generation of virus-like particles: Successes and challenges

(2013) Fuxiao Liu et al.   PROTEIN EXPRESSION AND PURIFICATION

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

(2013) Ashley J. Birkett et al.   VACCINE

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

N-Terminal Prodomain of Pfs230 Synthesized Using a Cell-Free System Is Sufficient To Induce Complement-Dependent Malaria Transmission-Blocking Activity

(2011) Mayumi Tachibana et al.   Clinical and Vaccine Immunology

A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum

(2011) Christine E. Farrance et al.   Clinical and Vaccine Immunology

Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen

(2011) Heinrich Lünsdorf et al.   Microbial Cell Factories

CBB staining protocol with higher sensitivity and mass spectrometric compatibility

(2010) Mario Pink et al.   ELECTROPHORESIS

Virus-like particles in vaccine development

(2010) António Roldão et al.   Expert Review of Vaccines